Show simple item record

dc.contributor.authorKaifeng Chen
dc.contributor.authorShan Jiang
dc.contributor.authorYun Hong
dc.contributor.authorZibiao Li
dc.contributor.authorYun-Long Wu
dc.contributor.authorCaisheng Wu
dc.date.accessioned2020-10-10T02:09:16Z
dc.date.available2020-10-10T02:09:16Z
dc.date.issued2019-12-26
dc.identifier.citationProgress in Natural Science: Materials International,2019,
dc.identifier.other10.1016/j.pnsc.2019.10.003
dc.identifier.urihttps://dspace.xmu.edu.cn/handle/2288/174821
dc.description.abstractAbstract(#br)CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/clustered regularly interspaced short palindromic repeat associated proteins 9) gene editing platform is a promising therapeutic tool for genetic disorders, due to its ability to manipulate the pathogenic gene in genomic level and to easily target specific gene by manipulating single-guide RNA. However, its successful delivery remains a challenge. Up to now, great efforts have been made to explore an effective strategy for CRISPR/Cas9 delivery. But among those delivery methods, physical methods are mainly operated on cultured cells thus limited to laboratorial use; viral vectors are hindered by fetal immunogenic and carcinogenic effects thus dubious in clinical application. Therefore, cationic polymeric vectors, with the ability to interact with CRISPR/Cas9 system to form a nanoformulation as a non-viral approach, are attracting increasing attentions, due to advantages such as well protection of cargos, less limitation in payload size, low immunogenicity or carcinogenicity, potential modifications for further functions, and ease in mass production. In this review, the recent discoveries on polymeric vectors utilized in delivery of CRISPR/Cas9 system will be summarized. With emphasis on advanced features of those polymeric vectors or their nanoformulations to meet the demands of different CRISPR/Cas9 delivery forms (plasmid, mRNA or protein), the detailed illustrations on their disease treatment applications, such as cancer, diabetes or antibiotic-resistant infections, will also be reviewed.
dc.language.isozh_CN
dc.subjectCRISPR/Cas9
dc.subjectPolymeric vectors
dc.subjectGene therapy
dc.subjectGene delivery
dc.subjectCancer therapy
dc.titleCationic polymeric nanoformulation: Recent advances in material design for CRISPR/Cas9 gene therapy
dc.typeArticle


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record